SCHEMBL3576183

SCHEMBL3576183

O=C(Nc1cc(F)cc(F)c1)Nc1ccc(-c2cccc(C(F)(F)F)c2)cc1-c1nnn[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.44
KIT P10721 5/20 0.44
FLT3 P36888 5/20 0.44
CSF1R P07333 4/20 0.44
FLT1 P17948 4/20 0.44
FYN P06241 3/20 0.44
FLT4 P35916 3/20 0.44
LCK P06239 2/20 0.44
LYN P07948 2/20 0.44
BLK P51451 2/20 0.44
ABL1 P00519 1/20 0.44
SRC P12931 1/20 0.44
GRIK1 P39086 1/20 0.43
PLK4 O00444 3/20 0.43
IGF1R P08069 1/20 0.42
RIPK1 Q13546 1/20 0.41
KIF11 P52732 1/20 0.41
NTRK1 P04629 3/20 0.41
NTRK2 Q16620 3/20 0.41
AURKB Q96GD4 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3570022 0.92 KDR (0.45) KDRKITFLT3CSF1RFLT1
SCHEMBL3584713 0.91 MTOR (0.41) KDRKITFLT3CSF1RFLT1
SCHEMBL3573627 0.90 P2RY1 (0.47) KDRKITFLT3CSF1RFLT1
SCHEMBL3586253 0.87 KDR (0.47) KDRKITFLT3CSF1RFLT1
SCHEMBL3577053 0.87 KDR (0.51) KDRKITFLT3CSF1RFLT1
SCHEMBL3580763 0.85 PSEN1 (0.45) KDRKITFLT3CSF1RFLT1
SCHEMBL5468866 0.84 GRIK1 (0.59) KDRKITFLT3CSF1RFLT1
SCHEMBL3581371 0.84 NTRK1 (0.53) KDRKITFLT3CSF1RFLT1
SCHEMBL5468482 0.84 IDH2 (0.53) KDRKITFLT3CSF1RFLT1
SCHEMBL5471923 0.83 GRIK1 (0.51) KDRKITFLT3CSF1RFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691891-B2 Diphenylurea derivatives and their use as chloride channel blockers NEUROSEARCH A/S (DK) 2010-04-06 US claimed
EP-1638948-B1 DIPHENYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS NEUROSEARCH AS (DK) 2008-10-15 EP claimed
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US claimed
US-20060178413-A1 Diphenylurea derivatives and their use as chloride channel blockers NEUSEARCH A/S (DK) 2006-08-10 US claimed
US-7691891-B2 Diphenylurea derivatives and their use as chloride channel blockers NEUROSEARCH A/S (DK) 2010-04-06 US disclosed
EP-1638948-B1 DIPHENYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS NEUROSEARCH AS (DK) 2008-10-15 EP disclosed
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US disclosed
US-20060178413-A1 Diphenylurea derivatives and their use as chloride channel blockers NEUSEARCH A/S (DK) 2006-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators KCNJ2, KCNH2, KCNH3 KDR 1142/4885KIT 1089/4885FLT3 2643/4885
US-20060178413-A1 Diphenylurea derivatives and their use as chloride channel blockers CLIC1, CLIC4, CLCN2 KDR 2480/4885KIT 4075/4885FLT3 3392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.